Novartis Challenges $1.3M Verdict In Zometa Jaw Injury Suit
Novartis Pharmaceutical Corp. moved for a new trial Friday immediately after a Florida jury awarded $1.3 million in damages to a Zometa user who allegedly suffered jaw death, pointing to a...To view the full article, register now.
Already a subscriber? Click here to view full article